Activation by alpha 1-adrenergic agonists of the progression phase in the proliferation of primary cultures of smooth muscle cells in mouse and rat aorta

Biological & Pharmaceutical Bulletin
Y MimuraM Kimura

Abstract

The effects of catecholamines on the competence and progression phases in the proliferation of vascular smooth muscle cells (SMCs) in mouse and rat were investigated in primary cultures: alpha,beta-Adrenergic agonists such as epinephrine and norepinephrine, and the alpha-adrenergic agonist, phenylephrine, stimulated proliferation of primary cultured SMCs, whereas the alpha 2-adrenergic agonist, clonidine, and beta-adrenergic agonist, isoproterenol, did not. The stimulating effect of epinephrine was maximal at 0.54 microM and was then decreased at higher concentrations. The alpha-adrenergic antagonist, phentolamine, and alpha 1-adrenergic antagonist, prazosin, inhibited epinephrine-induced SMC proliferation, while the alpha 2-adrenergic antagonist, yohimbine, and beta-adrenergic antagonist, propranolol, did not. In primary cultured and synchronized SMCs at the G0 phase, norepinephrine accelerated the rate of SMC proliferation, but did not change the starting time of DNA synthesis and proliferation. These results show that catecholamines activate the progression phase in primary cultured aortic SMCs alpha 1-adrenergic receptors.

Citations

May 19, 2005·Naunyn-Schmiedeberg's Archives of Pharmacology·Beilei LeiDebra A Schwinn
May 21, 1999·The Journal of Surgical Research·M G DaviesP O Hagen
Dec 31, 2004·Arteriosclerosis, Thrombosis, and Vascular Biology·Kristen JohnsonRobert Terkeltaub
Jun 5, 2003·The Journal of Clinical Investigation·Stephanie ThebaultNatalia Prevarskaya
Dec 12, 2001·The Journal of Biological Chemistry·Debi K SwertfegerDavid Y Hui
May 18, 1999·Journal of Investigative Surgery : the Official Journal of the Academy of Surgical Research·M G Davies, P O Hagen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.